3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Classical hematology
1
Conditions
Venous Thromboembolism
15
Venous Thrombosis
11
Pulmonary Embolism
10
Neoplasms
9
Thrombosis
4
Thromboembolism
4
Pancreatic Neoplasms
4
Lung Neoplasms
4
Multiple Myeloma
3
Neoplasm Metastasis
2
Lymphoma
2
Hemorrhage
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Thrombophilia
1
Thrombocytopenia
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Obesity
1
Neoplasms, Plasma Cell
1
Interventions
Exercise
24
Metformin
23
Resistance Training
8
Nutrition Assessment
8
Methods
8
Tirzepatide
7
Diet Therapy
7
Diet
7
Counseling
7
Early Intervention, Educational
6
Caloric Restriction
6
Exenatide
5
semaglutide
4
Liraglutide
4
Educational Status
4
Docosahexaenoic Acids
4
Diet, Mediterranean
4
Vitamin D
3
Therapeutics
3
Surveys and Questionnaires
3
Sugars
3
Standard of Care
3
Dexamethasone
3
Yoga
2
Tablets
2
Specimen Handling
2
Progestins
2
Ovidrel
2
Nutritional Status
2
Naltrexone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Obesity
×
Dalteparin
×
Clear all
NCT03297359
2024-01-23
WAVe
Ottawa Hospital Research Institute
Phase 2
Terminated
92 enrolled